Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ADAM10 |
| Upstream (Parents) |
|---|
| (<<) CTNNB1 → ADAM10 |
| (<<) DHX9 → ADAM10 |
| (<<) HSPA4 → ADAM10 |
| (<<) HSPA5 → ADAM10 |
| (<<) PGK1 → ADAM10 |
| (<<) PRPF4B → ADAM10 |
| (<<) TAF9 → ADAM10 |
| (<<) YWHAZ → ADAM10 |
| Downstream (Children) |
|---|
| ADAM10 → ADAMTS7 (>>) |
| ADAM10 → ARAF (>>) |
| ADAM10 → CASP3 (>>) |
| ADAM10 → CAV3 (>>) |
| ADAM10 → CPD (>>) |
| ADAM10 → EML4 (>>) |
| ADAM10 → EZR (>>) |
| ADAM10 → GSTK1 (>>) |
| ADAM10 → MAPK6 (>>) |
| ADAM10 → MYO1E (>>) |
| ADAM10 → PDIA3 (>>) |
| ADAM10 → PIK3CA (>>) |
| ADAM10 → PLOD2 (>>) |
| ADAM10 → PTPN12 (>>) |
| ADAM10 → RB1 (>>) |
| ADAM10 → RBM7 (>>) |
| ADAM10 → ROCK1 (>>) |
| ADAM10 → STAM2 (>>) |
| ADAM10 → UTP18 (>>) |
